R(+)-baclofen, but not S(-)-baclofen, alters alcohol self-administration in alcohol-preferring rats
Racemic baclofen [(±)-baclofen] has repeatedly been reported to suppress several alcohol-motivated behaviors, including alcohol drinking and alcohol self-administration, in rats and mice.
Irene eLorrai +3 more
doaj +4 more sources
Metabolic and Pharmacokinetic Differentiation of STX209 and Racemic Baclofen in Humans
STX209 is an exploratory drug comprising the single, active R-enantiomer of baclofen which is in later stage clinical trials for the treatment of fragile x syndrome (FXS) and autism spectrum disorders (ASD).
Raymundo Sanchez-Ponce +5 more
doaj +3 more sources
FABRICATION OF TOPICAL BACLOFEN LOADED EMULGEL: CHARACTERIZATION, OPTIMIZATION USING 23 FULL FACTORIAL DESIGN AND IN VIVO ANTI-INFLAMMATORY ACTIVITY [PDF]
Baclofen is a GABA-B receptors agonist and possesses anti-inflammatory properties. It has many gastrointestinal side effects and narrow therapeutic index. Thus, the objective of this study was to produce emulgel for the topical delivery of baclofen so as
Nabaweya El Gawad +4 more
doaj +1 more source
Baclofen-induced myoclonus in patients with renal impairment: A case series
Baclofen is a derivative of gamma amino butyric acid and is used for control of pain and muscular spasms. It is primarily excreted via the kidneys. In patients with impaired renal functions, the half-life of baclofen is prolonged and symptoms of toxicity
Manudi Nushara Vidanapathirana +2 more
doaj +1 more source
Baclofen therapeutics, toxicity, and withdrawal: A narrative review
Baclofen is an effective therapeutic for the treatment of spasticity related to multiple sclerosis, spinal cord injuries, and other spinal cord pathologies.
Jia W Romito +7 more
doaj +1 more source
Prepontine baclofen catheter placement: A case report and technical illustration
Background: Intrathecal baclofen (ITB) is used for medically refractory spasticity and dystonia. There are times when intraventricular baclofen (IVB) is used as a last resort for patients who cannot tolerate or cannot receive intrathecal baclofen through
Josue D. Ordaz, Jacob Archer, Albert Lee
doaj +1 more source
Mechanism of Baclofen Inhibiting the Proliferation and Metastasis of GBM by Regulating YAP
This study explores the effect of baclofen on the malignant phenotype of glioblastoma (GBM) and the growth of xenograft tumors and investigates the related mechanisms, aiming to reveal the effect of baclofen on the occurrence and development of GBM.
Lin Zhu, Juan Lu, Zhijun Bao, Shiwen Guo
doaj +1 more source
Summary A 57-year-old woman suffering from multiple sclerosis took an estimated 1500 mg of baclofen. She became deeply unconscious with generalized flaccid muscle paralysis and absent tendon reflexes. Toxicological analysis confirmed the presence of baclofen together with small amounts of paracetamol and glutethimide. Supportive therapy,
D J, Lipscomb, T J, Meredith
openaire +2 more sources
Introduction: Clinical studies on the effectiveness of Baclofen in alcohol use disorder (AUD) yielded mixed results possibly because of differential effects of the enantiomers and sex-related differences.
Jérôme Jeanblanc +16 more
doaj +1 more source
Stability Study of Baclofen in an Oral Powder Form Compounded for Pediatric Patients in Japan
Baclofen is used as a skeletal muscle relaxant for multiple sclerosis patients and pediatric patients with cerebral palsy and is prescribed to pediatric patients at 0.3 to 1.0 mg/kg/dose.
Jumpei Saito +7 more
doaj +1 more source

